相关实验视频
Updated: Sep 17, 2025
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
DDX3X/MAVS通过调节压力颗粒来缓解多克索鲁比诱导的心脏毒性
Kaixiang Zhao1, Shaochen Wang1, Dandan Feng2
1Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan, Shandong 250014, P.R China.
Molecular medicine reports
|June 27, 2025
概括
通过调节应力颗粒 (SGs),DEAD-box RNA基酶3X链接 (DDX3X) 和线粒体抗病毒信号传导 (MAVS) 通过调节应力颗粒 (SGs) 来保护免受多克索鲁比诱导的心脏毒性. 这一发现为预防化疗引起的心脏损伤提供了新的见解.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 多克索鲁比 (Dox) 是一种广泛使用的化疗剂,但由于心脏毒性,其使用受到限制.
- 导致Dox诱导心脏毒性 (DIC) 的精确分子机制尚未完全理解.
- 识别对DIC的保护因素对于改善患者的治疗结果至关重要.
研究的目的:
- 为了研究DEAD-boxRNA螺旋酶3X链接 (DDX3X),线粒体抗病毒信号 (MAVS) 和压力颗粒 (SGs) 在Dox诱导的心脏毒性的作用.
- 在DIC的背景下,阐明连接DDX3X,MAVS和SG的分子通路.
- 确定DDX3X,MAVS和SG是否可以作为针对DIC的治疗干预的目标.
主要方法:
- H9c2心肌细胞被用多克索鲁比治疗.
- 评估了DDX3X,MAVS和SG的水平.
- 使用药理学药物 (石,异胺) 和基因操纵 (敲击,过度表达) 来调节SG形成和DDX3X活性.
- 西部涂抹,逆转录定量PCR,免疫光学和流细胞计被用于分析.
主要成果:
- Dox治疗导致H9c2心肌细胞中DDX3X,MAVS和SGs水平降低.
- 用酸盐 (SG增强剂) 的预处理缓解了Dox诱导的心肌损伤,而异素 (SG抑制剂) 则加剧了损伤.
- DDX3X的淘汰/抑制降低了SG的表达,而DDX3X的过度表达促进了SG的产生.
- MAVS knockdown 抑制了 SG 组合和降低了 Bcl2 表达,表明 MAVS 作为 DDX3X 和 SGs 之间的链接.
结论:
- 通过调节应力颗粒形成,DDX3X可以减轻Dox引起的心脏毒性.
- MAVS作为一个关键的中间体,将DDX3X连接到SG组件,并影响抗亡途径.
- DDX3X,MAVS和SG代表了对Dox诱导的心脏毒性和潜在治疗点的关键保护因素.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
64
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
64
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
42
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
42
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
01:26Heart Failure Drugs: Inotropic Agents
743
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
743
01:29Cardiomyopathy V: Interprofessional Care
40
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
40